Avanos Medical (NYSE: AVNS) has announced that it will be unveiling its third quarter financial results on Wednesday 30th October 2024. The disclosure is planned to occur before market open.
According to financial analysts on Wall Street, the firm is likely to announce an estimated per share $0.35 profit for the quarter. Additionally, the company is anticipated to reveal a total revenue of $175.33 million during this period.
The earnings report for the corresponding quarter of the prior year unveiled a per-share income of $0.3. This was a direct result of the company's total revenue, which amounted to an impressive $171.3 million during that specific period.
According to the Wall Street analysts projections, the company is expected to generate a total revenue of $695.23 million for the fiscal year. Additionally, these analysts anticipate that the company will report profit of $1.39 per share during the same period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.34 | +41.7% | 171.70 M | +1.4% |
| Q1 2024 | $0.19 | -29.6% | 166.10 M | -13.4% |
| Q4 2023 | $0.36 | -40.0% | 173.30 M | -20.3% |
| Q3 2023 | $0.30 | -21.1% | 171.30 M | -15.2% |
| Q2 2023 | $0.24 | -41.5% | 169.40 M | -16.6% |
| *Growth on year-over-year basis | ||||
AVNS has scheduled a conference call on 30th October 2024 at 09:00 AM eastern time to discuss the third quarter financial results and other related information.
Avanos Medical (AVNS) shares traded as low as $22.46 and as high as $22.86 on a day volume of 130.50 thousand shares, closed Monday's regular trading session at $22.62, an upturn of 1.25 percent.
